Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Medical Case Reports|September 8, 2016
Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case reportMurray G Tucker, Sebastian Kekulawala, Michelle Kent, et al.
The Pharmacogenomics Journal|October 17, 2019
Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severityDorothea Lesche, Sam Mostafa, Ian Everall, et al.
Clinical Pharmacology and Therapeutics|May 7, 2026
A Review of Virtual Twins in Physiologically-Based Pharmacokinetic Modeling and SimulationEmily Mannix, Sam Mostafa, Amin Rostami-Hodjegan, et al.
Pharmacogenetics and Genomics|May 21, 2020
Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patientsChaten D Jessel, Sam Mostafa, Maria Potiriadis, et al.
The Pharmacogenomics Journal|November 8, 2023
Cytochrome P450-2D6 activity in people with codeine use disorderMark R C Daglish, Sarah R Reilly, Sam Mostafa, et al.
Pharmacogenomics|September 28, 2022
Pharmacogenomics in psychiatry - the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosingSam Mostafa, Thomas M Polasek, Chad A Bousman, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 25, 2022
Delineating gene-environment effects using virtual twins of patients treated with clozapineSam Mostafa, Thomas M Polasek, Chad Bousman, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2024
Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophreniaSam Mostafa, Reza Rafizadeh, Thomas M Polasek, et al.
Pageof 1